Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 3,576 WGS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | GeneDx Holdings Corp. (WGS) | Exercise/Conversion | 3,576 | n/a |
| Jun 22, 2026 | OPKO HEALTH, INC. (OPK) | Grant/Award | 60,000 | n/a |
| Jun 18, 2026 | Fluent, Inc. (FLNT) | Grant/Award | 30,096 | n/a |
| Jun 18, 2026 | Fluent, Inc. (FLNT) | Grant/Award | 21,429 | n/a |
| Jan 13, 2026 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 16,410 | n/a |
| Oct 30, 2025 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 20,000 | n/a |
| Jun 23, 2025 | GeneDx Holdings Corp. (WGS) | Exercise/Conversion | 12,924 | n/a |
| Jun 23, 2025 | Fluent, Inc. (FLNT) | Grant/Award | 39,682 | n/a |
| May 5, 2025 | GeneDx Holdings Corp. (WGS) | Exercise/Conversion | 918 | n/a |
| Apr 23, 2025 | OPKO HEALTH, INC. (OPK) | Grant/Award | 60,000 | n/a |